Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

DNA shuffling and screening strategies for improving vaccine efficacy.

Locher CP, Paidhungat M, Whalen RG, Punnonen J.

DNA Cell Biol. 2005 Apr;24(4):256-63. Review.

PMID:
15812242
2.

Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies.

Locher CP, Heinrichs V, Apt D, Whalen RG.

Expert Opin Biol Ther. 2004 Apr;4(4):589-97. Review.

PMID:
15102607
3.

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.

Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS.

Vaccine. 2009 Jun 24;27(31):4152-60. doi: 10.1016/j.vaccine.2009.04.049. Epub 2009 May 9.

PMID:
19406186
4.

Development of novel vaccines using DNA shuffling and screening strategies.

Locher CP, Soong NW, Whalen RG, Punnonen J.

Curr Opin Mol Ther. 2004 Feb;6(1):34-9. Review.

PMID:
15011779
5.

Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.

Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J.

Vaccine. 2006 Jan 16;24(3):335-44. Epub 2005 Aug 10.

PMID:
16125280
6.

Molecular breeding of allergy vaccines and antiallergic cytokines.

Punnonen J.

Int Arch Allergy Immunol. 2000 Mar;121(3):173-82. Review.

PMID:
10729775
7.

A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.

Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K.

Virology. 2006 Sep 15;353(1):166-73. Epub 2006 Jun 30.

8.

In vitro rapid evolution of fungal immunomodulatory proteins by DNA family shuffling.

Wang XF, Li QZ, Bao TW, Cong WR, Song WX, Zhou XW.

Appl Microbiol Biotechnol. 2013 Mar;97(6):2455-65. doi: 10.1007/s00253-012-4131-z. Epub 2012 May 22.

PMID:
22615051
9.

Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.

Phillips AT, Schountz T, Toth AM, Rico AB, Jarvis DL, Powers AM, Olson KE.

J Virol. 2014 Feb;88(3):1771-80. doi: 10.1128/JVI.02297-13. Epub 2013 Nov 20.

10.

DNA vaccines expressing antigens with a stress protein-capturing domain display enhanced immunogenicity.

Reimann J, Schirmbeck R.

Immunol Rev. 2004 Jun;199:54-67. Review.

PMID:
15233726
11.
12.
13.

DNA vaccination: antigen presentation and the induction of immunity.

Shedlock DJ, Weiner DB.

J Leukoc Biol. 2000 Dec;68(6):793-806. Review.

PMID:
11129646
14.

Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.

Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H.

Vaccine. 2007 Jul 9;25(28):5155-65. Epub 2007 May 21.

PMID:
17548134
15.

Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.

Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.

Cancer Res. 2002 Oct 15;62(20):5845-52.

16.

CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.

Ma J, Wang H, Zheng X, Xue X, Wang B, Wu H, Zhang K, Fan S, Wang T, Li N, Zhao Y, Gao Y, Yang S, Xia X.

Int Immunopharmacol. 2014 Mar;19(1):74-80. doi: 10.1016/j.intimp.2014.01.002. Epub 2014 Jan 17.

PMID:
24440303
17.

Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination.

Nagata T, Aoshi T, Uchijima M, Suzuki M, Koide Y.

DNA Cell Biol. 2004 Feb;23(2):93-106. Review.

PMID:
15000749
18.

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.

Richie TL, Charoenvit Y, Wang R, Epstein JE, Hedstrom RC, Kumar S, Luke TC, Freilich DA, Aguiar JC, Sacci JB Jr, Sedegah M, Nosek RA Jr, De La Vega P, Berzins MP, Majam VF, Abot EN, Ganeshan H, Richie NO, Banania JG, Baraceros MF, Geter TG, Mere R, Bebris L, Limbach K, Hickey BW, Lanar DE, Ng J, Shi M, Hobart PM, Norman JA, Soisson LA, Hollingdale MR, Rogers WO, Doolan DL, Hoffman SL.

Hum Vaccin Immunother. 2012 Nov 1;8(11):1564-84. doi: 10.4161/hv.22129. Epub 2012 Nov 1.

19.

Novel strategies to improve DNA vaccine immunogenicity.

Coban C, Kobiyama K, Aoshi T, Takeshita F, Horii T, Akira S, Ishii KJ.

Curr Gene Ther. 2011 Dec;11(6):479-84. Review.

PMID:
22023477

Supplemental Content

Support Center